respondents also occasionally listed commercial interests among the drivers of stratified medicine only in finland and israel did this appear to be a prominent concern however while one chinese respondent anticipated rather different benefits in the form of a move towards introducing elements of a market economy into healthcare thus while respondents were able to cite occasional examples of successful stratification of medical interventions haematological cancers in finland and lung cancer in luxembourg for instance these were predominantly local examples both geographically and in terms of being confined to a few quite specific conditions while the general view among respondents was that it was still too early to look for significant improvements in healthcare attributable to stratified medicine